Your Client Rank:
Loading...
99
Updated 26-Sep-2020
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Eisai | 12.5% | 0.7% | -1.8% | -9.1% | 16.8% | 2.3% | 30.4% | 30.4% |
| Vertex | 11.2% | 0.3% | -3.0% | -5.9% | 4.8% | 9.5% | 14.1% | 13.3% |
| Astra | 10.6% | 0.4% | -5.3% | -3.3% | 8.9% | -0.2% | 18.7% | 18.8% |
| Daiichi | 9.3% | 2.7% | -2.0% | -5.0% | 24.4% | -0.2% | 35.1% | 35.6% |
| Mylan | 8.7% | 2.9% | -0.9% | -1.3% | 5.8% | -2.8% | 17.7% | -0.5% |
| Lilly | 7.9% | 0.6% | -4.2% | -4.3% | 4.3% | 0.7% | 10.9% | 11.6% |
| Novo | 7.4% | -0.1% | -1.3% | 0.7% | 0.2% | 0.1% | 7.9% | 10.2% |
| Alexion | 7.0% | 0.0% | -1.4% | 1.8% | 0.3% | 0.1% | 8.0% | 9.5% |
| Regeneron | 6.9% | -0.2% | -1.1% | -3.3% | 0.8% | 9.9% | 7.9% | 7.2% |
| Roche | 4.8% | 0.3% | -1.0% | -0.6% | 1.4% | 0.7% | 6.8% | 6.8% |
| Merck KG | 4.6% | 0.0% | -1.6% | -1.8% | 6.6% | 0.1% | 8.1% | 8.9% |
| Merck | 4.5% | 0.8% | -2.2% | -2.1% | 2.8% | 1.4% | 7.6% | 8.6% |
| Chugai | 4.4% | 1.2% | -1.0% | 0.0% | 2.6% | -0.1% | 7.4% | 7.4% |
| AbbVie | 4.2% | -0.4% | -0.5% | -0.7% | -0.1% | 2.2% | 4.7% | 4.2% |
| Astellas | 4.1% | -0.2% | -1.2% | -2.9% | 3.9% | 0.4% | 8.1% | 14.5% |
| Glaxo | 3.9% | 0.4% | -1.5% | 0.7% | 2.4% | 3.4% | 6.5% | 6.3% |
| JnJ | 3.9% | 0.7% | -1.1% | -1.3% | 1.5% | 0.8% | 5.2% | 6.4% |
| Lundbeck | 3.6% | 0.8% | -2.0% | -4.9% | 18.7% | -2.8% | 10.7% | 10.7% |
| Sanofi | 3.5% | 0.6% | -3.7% | -3.2% | 5.1% | -0.3% | 7.0% | 7.5% |
| Novartis | 3.2% | 0.1% | -0.3% | -1.0% | 2.6% | 0.4% | 6.2% | 6.8% |
| Amgen | 3.0% | -0.2% | -0.5% | -0.1% | 0.0% | 0.5% | 3.8% | 5.7% |
| Bristol | 2.8% | -0.5% | -1.5% | -1.0% | 1.2% | -0.1% | 5.0% | 6.4% |
| UCB | 2.3% | 0.1% | 0.0% | -2.4% | 2.9% | 2.2% | 8.3% | 5.6% |
| Pfizer | 1.9% | 0.3% | -1.5% | -1.9% | 1.4% | 1.0% | 3.4% | 4.7% |
| Takeda | 1.4% | 0.4% | -2.2% | -2.2% | 17.5% | -19.0% | 48.0% | 47.9% |
| Bayer | 1.2% | -0.4% | -0.3% | 0.2% | 2.7% | 17.9% | 4.3% | 4.4% |
| Teva | 0.8% | 0.5% | -0.6% | -1.4% | 2.0% | 0.8% | 4.7% | 4.5% |
| Gilead | -0.5% | -0.1% | -0.2% | -0.9% | 1.2% | 0.1% | 1.4% | 2.4% |
| Biogen | -2.5% | -0.5% | 3.6% | 1.6% | -2.4% | 0.4% | -5.9% | -3.4% |
| Shionogi | | | | | | | | |
| EU Major | 4.4% | 0.4% | -1.7% | -0.8% | 3.3% | -0.1% | 7.7% | 8.0% |
| Other EU | 4.0% | 0.1% | -1.3% | -2.7% | 6.8% | 0.6% | 8.5% | 8.0% |
| US Major | 3.9% | 0.3% | -1.6% | -1.7% | 1.5% | 1.0% | 5.6% | 7.1% |
| US Big Biotech | 2.6% | -0.1% | -0.4% | -0.7% | 0.4% | 1.1% | 3.6% | 4.6% |
| Other US | 4.3% | 1.8% | -0.8% | -1.8% | 4.3% | -1.2% | 11.4% | 1.4% |
| Japanese | 4.7% | 0.8% | -1.3% | -3.1% | 12.1% | -6.8% | 24.2% | 28.4% |
